Investor Says Teva Pharma Lied About Price-Hike Scheme
A Swedish investment firm Wednesday accused Teva Pharmaceuticals in Connecticut federal court of lying to shareholders about an alleged scheme to pump up its share prices through a series of unsustainable...To view the full article, register now.
Already a subscriber? Click here to view full article